{"id":"W2791308824","doi":"10.1158/1078-0432.ccr-17-3452","title":"Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":387,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Breast cancer; Internal medicine; Oncology; Adverse effect; Cancer; Response Evaluation Criteria in Solid Tumors; Estrogen receptor; Nausea; Gastroenterology; Phases of clinical research; Toxicity; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001027858,0.0002537565,0.0007856857,0.0002130682,0.0002126712,0.00002157816,0.0002070317,0.0001872202,0.001776652],"category_scores_gemma":[0.0002780981,0.000192448,0.0001247299,0.0007265909,0.002272012,0.0002583296,0.0001434074,0.0008487088,0.000008762104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005867533,"about_ca_system_score_gemma":0.0007950383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003990219,"about_ca_topic_score_gemma":0.0008644076,"domain_scores_codex":[0.9965217,0.0006016206,0.0006928317,0.0007261695,0.0008144678,0.0006432359],"domain_scores_gemma":[0.9972336,0.0005777781,0.0002598228,0.0003676374,0.001262545,0.0002985855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1027604,0.000735931,0.7898188,0.0001418992,0.0002776475,0.000004444007,0.0002762908,2.698322e-7,0.007446384,0.00002485278,0.0004017036,0.09811132],"study_design_scores_gemma":[0.01612655,0.003589353,0.9632673,0.0006955278,0.00002712833,0.000002130673,0.00006103801,0.000008211175,0.01541302,0.00001351736,0.0005845329,0.0002116861],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952664,0.0003202661,0.000006242271,0.001758118,0.0002024404,0.001212126,0.0008559481,0.00002114197,0.0003572971],"genre_scores_gemma":[0.9975245,0.001436674,0.0001385435,0.0001654608,0.0003493106,0.00009610609,0.00002574433,0.00004557508,0.0002180655],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1734485,"threshold_uncertainty_score":0.9991359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06109298004932549,"score_gpt":0.4370445413124408,"score_spread":0.3759515612631153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}